Semi-Annual Statement Of Income And Retained Earnings

Delta-Fly Pharma, Inc. - Filing #7296920

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-916,306,000 JPY
-593,450,000 JPY
Non-operating income
Non-operating income
409,000 JPY
8,000 JPY
Non-operating expenses
Non-operating expenses
JPY
5,594,000 JPY
Ordinary profit (loss)
-915,896,000 JPY
-599,036,000 JPY
Profit (loss) before income taxes
-915,896,000 JPY
-599,036,000 JPY
Income taxes - current
1,251,000 JPY
1,251,000 JPY
Profit (loss)
-917,147,000 JPY
-600,287,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.